Similar articles

• Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.

  Da Silva VF, Bormanis J. Da Silva VF, et al. Neurosurgery. 1992 Jun;30(6):943-5. doi: 10.1227/00006123-199206000-00025. Neurosurgery. 1992. PMID: 1614602 Review.
• [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].

  Motomiya T. Motomiya T. Nihon Rinsho. 2003 Apr;61 Suppl 4:441-5. Nihon Rinsho. 2003. PMID: 12735012 Review. Japanese. No abstract available.
• An overview of the patency and stroke rates following thrombolysis with streptokinase, alteplase, and anistreplase used to treat an acute myocardial infarction.

  Baxter-Jones CS, White HD, Anderson JL. Baxter-Jones CS, et al. J Interv Cardiol. 1993 Mar;6(1):15-23. doi: 10.1111/j.1540-8183.1993.tb00437.x. J Interv Cardiol. 1993. PMID: 10171637 Review.
• [Ischemic ictus during thrombolytic treatment in acute myocardial infarct].

  Seijo-Martínez M, Pais A, Castro del Río M, Silva-Martínez M. Seijo-Martínez M, et al. Rev Neurol. 2000 Oct 16-31;31(8):798-9. Rev Neurol. 2000. PMID: 11082894 Spanish. No abstract available.
• Mental Dullness after thrombolytic therapy.

  Woo KS, Chan HC, Poon WS. Woo KS, et al. Postgrad Med J. 1997 Jun;73(860):347-9. doi: 10.1136/pgmj.73.860.347. Postgrad Med J. 1997. PMID: 9246336 Free PMC article. No abstract available.